British regulator authorizes use of AstraZeneca/Oxford vaccine
London, Dec. 30, (dpa/GNA) – Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of the vaccine developed by AstraZeneca and Oxford University, the government says.
« Now the NHS will begin putting their extensive preparations into action to roll out the Oxford University/AstraZeneca vaccine, » says the government statement.
The vaccine is the second to be approved for usage in Britain.
The Pfizer/BioNTech vaccine was the first jab given the green light in Britain by the MHRA on December 2 and began being rolled out to vulnerable and elderly people the following week.
« With two vaccines now approved, we will be able to vaccinate a greater number of people who are at highest risk, protecting them from the disease and reducing mortality and hospitalisation, » adds the statement.
GNA
